Search

Coal, oil, and gas account for over 75% of total global greenhouse gas emissions and nearly 90% of all carbon dioxide emissions. Biotechnology is crucial in reducing the use of fossil fuels and in the

Europe aims to progress towards a more sustainable and resilient food system through the development of improved plant varieties. Following the vote on February 7th, the European Parliament will be

The Parliament is expected to adopt its mandate during the plenary session on February 7, 2024, after which it will be ready to commence negotiations with EU Member States. It is crucial not to miss

Immunotherapy, gene therapy, the study of mRNA and its potential application in vaccines, nanotechnology, liquid biopsy, the development of specific biomarkers, and CAR-T cells are just a few examples

Members of the European Parliament have agreed with the proposal to have two different categories and two sets of rules for plants derived from the use of NGTs. The total ban on patents for all plants

The 2024 program application will open on January 25th and close on February 21st. The 2024 edition format includes a 40-hour service package for three companies that includes an initial meeting

This is evident in the study conducted by EuropaBio, titled "Impact of the General Pharmaceutical Legislation of the European Union on the Innovation Ecosystem and Biotechnological Companies in Europe

The technical meeting and collaborative forum have been held under the title "Applications of non-viral vectors in gene editing and therapy: Challenges for academia and industry." More than 30

In the upcoming month of November, the Spanish Association of Biocompanies (AseBio) will celebrate its 25th anniversary. The milestone will shape AseBio's work throughout 2024 through various actions

In the General Assembly of AseBio, new vice-presidents have also been elected: Carlos Buesa, CEO of Oryzon (First Vice-presidency); Cristina Nadal, Policy Executive Director of MSD Spain (Second Vice

The list, comprised of 268 drugs, is an important tool to support the EU's efforts to ensure the security of the supply chain and prevent shortages of critical medications. Over the last 40 years

The purpose behind our request for the creation of the High Commissioner is to strengthen Spain's commitment to deep technologies at a critical moment for Europe's strategic autonomy.

The biotech sector provides cross-cutting solutions ranging from the diagnosis, research, and treatment of infectious diseases to the development of innovative preventive and therapeutic strategies

Beyond the direct impact of biotechnology on human health and the planet, investment in science and biotechnology has a direct relationship with the competitiveness, sustainability, and economic

The President of the Generalitat de Catalunya, Pere Aragonès i Garcia, and the General Manager of Amgen and member of the Board of Directors of AseBio and the Board of Trustees of Biocat, Fina Lladós

Ensuring food security and mitigating the impacts of climate change will not be possible without innovation in agriculture. Through food waste and the insect industry, proteins are being produced in a

The majority of biotechnology companies are small and micro-enterprises that do not have products on the market and do not generate the necessary resources to finance their activities. There is an

The sector has radically transformed the discovery of new drugs and therapeutic solutions. Worldwide, there are over 300 approved medications for approximately 250 indications and a thousand molecules

The new edition of the international flagship event in the biotech sector will take place in Barcelona from September 26 to 28, in collaboration with Biocat, the Government of Catalonia, and the

The European project ShapingBio, created with the aim of better understanding and gaining knowledge of the innovation ecosystem in the European bioeconomy sector, will be present at BIOSPAIN. Under

During the Presidency of the Council of the European Union, Spain will lead the dialogue on these critical policies for European patients, food safety, and the green transition. "We need to find a